» Articles » PMID: 17761631

The Roles of Different Pathways in the Release of Cholesterol from Macrophages

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 2007 Sep 1
PMID 17761631
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol efflux occurs by different pathways, including transport mediated by specific proteins. We determined the effect of enriching cells with free cholesterol (FC) on the release of FC to human serum. Loading Fu5AH cells with FC had no effect on fractional efflux, whereas enriching mouse peritoneal macrophages (MPMs) resulted in a doubling of fractional efflux. Efflux from cholesterol-normal MPM and Fu5AH cells to 15 human sera correlated well with HDL parameters. However, these relationships were reduced or lost with cholesterol-loaded MPMs. Using macrophages from scavenger receptor class B type I (SR-BI)-, ABCA1-, and ABCG1-knockout mice, together with inhibitors of SR-BI- and ABCA1-mediated efflux, we were able to quantitate efflux upon loading macrophages with excess cholesterol and to establish the contributions of the various efflux pathways in cholesterol-normal and -enriched cells. The removal of ABCA1 had essentially no effect on the total efflux when cell cholesterol levels were normal. However, in cholesterol-enriched cells, the removal of ABCA1 reduced efflux by 50%. Approximately 20% of the efflux stimulated by FC-loading MPM is attributable to ABCG1. The SR-BI contribution to efflux was small. Another pathway that is present in all cells is aqueous diffusion. Our studies demonstrate that this mechanism is one of the major contributors to efflux, particularly in cholesterol-normal cells.

Citing Articles

Indole-3-Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR-1271-5p/HDAC9 Pathway.

Luo W, Meng J, Yu X, Zhang Z, Wang G, He J J Cell Mol Med. 2024; 28(24):e70263.

PMID: 39698913 PMC: 11656405. DOI: 10.1111/jcmm.70263.


Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis.

La Chica Lhoest M, Martinez A, Claudi L, Garcia E, Benitez-Amaro A, Polishchuk A Front Cardiovasc Med. 2024; 11:1381520.

PMID: 38952543 PMC: 11215187. DOI: 10.3389/fcvm.2024.1381520.


TNFAIP1 promotes macrophage lipid accumulation and accelerates the development of atherosclerosis through the LEENE/FoxO1/ABCA1 pathway.

Xu C, Meng J, Yu X, Wang R, Li M, Yin S J Physiol Biochem. 2024; 80(3):523-539.

PMID: 38878215 DOI: 10.1007/s13105-024-01018-x.


Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.

White M, Wong J, Damania B Cancer Res Commun. 2024; 4(4):1024-1040.

PMID: 38592451 PMC: 11003453. DOI: 10.1158/2767-9764.CRC-23-0430.


The role of foam cells in spinal cord injury: challenges and opportunities for intervention.

Wang X, Li Z, Du H, Liu W, Zhang C, Xu X Front Immunol. 2024; 15:1368203.

PMID: 38545108 PMC: 10965697. DOI: 10.3389/fimmu.2024.1368203.